![]() |
Volumn 4 Suppl 1, Issue , 1997, Pages 27-32
|
Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B ANTIBODY;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
VIRUS DNA;
ADULT;
ARTICLE;
BLOOD;
CELL CULTURE;
CHRONIC DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
VIROLOGY;
ADULT;
ALANINE TRANSAMINASE;
ANTIVIRAL AGENTS;
CHRONIC DISEASE;
DNA, VIRAL;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B E ANTIGENS;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR CELLS, CULTURED;
|
EID: 0030625649
PISSN: 13520504
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2893.1997.tb00157.x Document Type: Article |
Times cited : (16)
|
References (0)
|